Joanna M. Wierońska

3.4k total citations
86 papers, 2.6k citations indexed

About

Joanna M. Wierońska is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Joanna M. Wierońska has authored 86 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Cellular and Molecular Neuroscience, 44 papers in Molecular Biology and 11 papers in Cognitive Neuroscience. Recurrent topics in Joanna M. Wierońska's work include Neuroscience and Neuropharmacology Research (65 papers), Receptor Mechanisms and Signaling (35 papers) and Neurotransmitter Receptor Influence on Behavior (18 papers). Joanna M. Wierońska is often cited by papers focused on Neuroscience and Neuropharmacology Research (65 papers), Receptor Mechanisms and Signaling (35 papers) and Neurotransmitter Receptor Influence on Behavior (18 papers). Joanna M. Wierońska collaborates with scholars based in Poland, United States and France. Joanna M. Wierońska's co-authors include Andrzej Pilc, Agnieszka Pałucha-Poniewiera, Piotr Brański, Bernadeta Szewczyk, Gabriel Nowak, Maria Śmiałowska, Mariusz Papp, Katarzyna Stachowicz, Paulina Cieślik and E Chojnacka-Wójcik and has published in prestigious journals such as Scientific Reports, Biological Psychiatry and Brain Research.

In The Last Decade

Joanna M. Wierońska

83 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joanna M. Wierońska Poland	29	1.9k	1.0k	579	487	304	86	2.6k
Krystyna Gołembiowska Poland	31	1.8k 1.0×	954 0.9×	335 0.6×	440 0.9×	306 1.0×	130	3.0k
Analı́a Bortolozzi Spain	31	1.7k 0.9×	1.2k 1.2×	372 0.6×	427 0.9×	353 1.2×	84	3.4k
Zofia Rogóż Poland	31	1.9k 1.0×	1000 1.0×	689 1.2×	751 1.5×	275 0.9×	162	3.1k
Nasser Haddjeri France	33	2.3k 1.2×	1.0k 1.0×	485 0.8×	991 2.0×	624 2.1×	92	3.4k
Agnieszka Pałucha-Poniewiera Poland	34	2.4k 1.3×	1.1k 1.1×	1.1k 1.8×	927 1.9×	422 1.4×	73	3.2k
Sharon C. Cheetham United Kingdom	29	1.5k 0.8×	845 0.8×	278 0.5×	558 1.1×	328 1.1×	70	2.8k
G Skuza Poland	28	1.4k 0.8×	850 0.8×	422 0.7×	555 1.1×	180 0.6×	110	2.2k
Tanya L. Wallace United States	25	1.5k 0.8×	1.3k 1.3×	287 0.5×	431 0.9×	431 1.4×	47	2.6k
Sungho Maeng South Korea	24	1.1k 0.6×	567 0.6×	874 1.5×	1.0k 2.1×	232 0.8×	54	2.7k
Zoë A. Hughes United States	28	949 0.5×	771 0.8×	381 0.7×	516 1.1×	333 1.1×	53	2.5k

Countries citing papers authored by Joanna M. Wierońska

Since Specialization

Citations

This map shows the geographic impact of Joanna M. Wierońska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna M. Wierońska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna M. Wierońska more than expected).

Fields of papers citing papers by Joanna M. Wierońska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna M. Wierońska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna M. Wierońska. The network helps show where Joanna M. Wierońska may publish in the future.

Co-authorship network of co-authors of Joanna M. Wierońska

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna M. Wierońska. A scholar is included among the top collaborators of Joanna M. Wierońska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna M. Wierońska. Joanna M. Wierońska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Płoska, Agata, Anna Siekierzycka, Paulina Cieślik, et al.. (2024). The Impact of LY487379 or CDPPB on eNOS Expression in the Mouse Brain and the Effect of Joint Administration of Compounds with NO• Releasers on MK-801- or Scopolamine-Driven Cognitive Dysfunction in Mice. Molecules. 29(3). 627–627. 1 indexed citations

Płoska, Agata, Adrianna Radulska, Anna Siekierzycka, et al.. (2024). The impact of mGlu2 or mGlu5 receptor activators on the production of l-arginine derivatives and the expression of PRMT5 or DDAH1 enzymes in animal models of cognitive decline. Nitric Oxide. 154. 140–151.

Cieślik, Paulina, et al.. (2023). A Comparative Study of the Impact of NO-Related Agents on MK-801- or Scopolamine-Induced Cognitive Impairments in the Morris Water Maze. Brain Sciences. 13(3). 410–410. 5 indexed citations

Stankiewicz, Anna, Ryszard Bugno, Maria H. Paluchowska, et al.. (2023). Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties. International Journal of Molecular Sciences. 24(3). 1981–1981. 8 indexed citations

Stankiewicz, Anna, Ryszard Bugno, Maria H. Paluchowska, et al.. (2021). New 1,2,4-oxadiazole derivatives with positive mGlu ₄ receptor modulation activity and antipsychotic-like properties. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 211–225. 4 indexed citations

Cieślik, Paulina, Anna Siekierzycka, Adrianna Radulska, et al.. (2021). Nitric Oxide-Dependent Mechanisms Underlying MK-801- or Scopolamine-Induced Memory Dysfunction in Animals: Mechanistic Studies. International Journal of Molecular Sciences. 22(22). 12282–12282. 12 indexed citations

Cieślik, Paulina, Adrianna Radulska, Grzegorz Burnat, Leszek Kalinowski, & Joanna M. Wierońska. (2021). Serotonergic–Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms. International Journal of Molecular Sciences. 22(16). 8612–8612. 8 indexed citations

Wierońska, Joanna M., Paulina Cieślik, & Leszek Kalinowski. (2021). Nitric Oxide-Dependent Pathways as Critical Factors in the Consequences and Recovery after Brain Ischemic Hypoxia. Biomolecules. 11(8). 1097–1097. 64 indexed citations

Cieślik, Paulina & Joanna M. Wierońska. (2020). Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery. International Journal of Molecular Sciences. 21(22). 8811–8811. 10 indexed citations

10.

Cieślik, Paulina, Adrianna Radulska, Iwona Pelikant‐Małecka, et al.. (2019). Reversal of MK-801-Induced Disruptions in Social Interactions and Working Memory with Simultaneous Administration of LY487379 and VU152100 in Mice. International Journal of Molecular Sciences. 20(11). 2781–2781. 17 indexed citations

11.

Cieślik, Paulina, Helena Domin, Agnieszka Chocyk, et al.. (2019). Simultaneous activation of mGlu2 and muscarinic receptors reverses MK-801-induced cognitive decline in rodents. Neuropharmacology. 174. 107866–107866. 13 indexed citations

12.

Latacz, Gniewomir, Adam S. Hogendorf, Annamaria Lubelska, et al.. (2018). Search for a 5-CT alternative. In vitro and in vivo evaluation of novel pharmacological tools: 3-(1-alkyl-1H-imidazol-5-yl)-1H-indole-5-carboxamides, low-basicity 5-HT₇ receptor agonists. MedChemComm. 9(11). 1882–1890. 25 indexed citations

13.

Wierońska, Joanna M., Monika Woźniak, Piotr Gruca, et al.. (2015). mGlu5-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia. Neurochemistry International. 88. 97–109. 24 indexed citations

14.

Wierońska, Joanna M., Anna Sławińska, Magdalena Łasoń, et al.. (2014). The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies. Psychopharmacology. 232(1). 259–273. 27 indexed citations

15.

Pałucha-Poniewiera, Agnieszka, Piotr Brański, Joanna M. Wierońska, et al.. (2013). The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent. Psychopharmacology. 231(1). 97–107. 24 indexed citations

16.

Wierońska, Joanna M., Piotr Brański, Agata Siwek, et al.. (2010). GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and increased reelin proteins in the hippocampus. Brain Research. 1334. 12–24. 17 indexed citations

17.

Kuter, Katarzyna, Maria Śmiałowska, Joanna M. Wierońska, et al.. (2007). Toxic influence of subchronic paraquat administration on dopaminergic neurons in rats. Brain Research. 1155. 196–207. 63 indexed citations

18.

Wierońska, Joanna M., Kinga Kłak, Agnieszka Pałucha-Poniewiera, Piotr Brański, & Andrzej Pilc. (2007). Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex. Brain Research. 1184. 88–95. 26 indexed citations

19.

Śmiałowska, Maria, Joanna M. Wierońska, Bernadeta Szewczyk, & Ewa Obuchowicz. (2003). Effect of some iono- and metabotropic glutamatergic ligands on neuropeptide Y immunoreactivity in the rat hippocampus.. PubMed. 54(6). 723–6. 4 indexed citations

20.

Wierońska, Joanna M., Mariusz Papp, & Andrzej Pilc. (2002). Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats.. PubMed. 53(5). 517–25. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact